Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock

[PR Newswire] – SAN DIEGO, Feb. 25, 2014 /PRNewswire/ — Neurocrine Biosciences, Inc. (NBIX) today announced that it is offering to sell 7,000,000 shares of its common stock in an underwritten public offering. In connection with this offering, Neurocrine more

View todays social media effects on NBIX

View the latest stocks trending across Twitter. Click to view dashboard

See who Neurocrine is hiring next, click here to view